Apply to Join
Jun 10, 2016

Treating 3500 poor TB patients in India & Cambodia

Dear Friend,

You will be delighted to know that the Lancet has published an article on Operation ASHA's innovative methodology, authored by Prof Ravi Anupindi and Prof Prashant Yadav of Ross school of Business, University of Michigan, and Prof Madhukar Pai, McGill University. Click here to access it. 

Also, the Huffington Post published Dr Shelly batra’s blog entitled “Technology: Killer or savior?” where she gave her views on how technology can, and must, be used for social good, and not for perpetrating war, terror and hatred. Click here to read it. 

Shelly was also invited to Oxford UK in mid April this year by the Skoll Foundation to participate in an event entitled “Beyond Dialogue: Building Sustainable and Inclusive Business Models in Partnership with Social Entrepreneur.” Operation ASHA generated a lot of interest among industry leaders, foundations, and civil society and government representatives.

Work goes on with greater momentum, and this year we hope for more partnerships, more work, greater impact, and I thank you with all my heart for your unswavering support.

Donation Utilization:

This quarter Operation ASHA raised $286.44. 

Thank you

Mar 15, 2016

Treating 3500 poor TB patients in India & Cambodia

Dear Friend,

This year has started with great accolades. Dr Shelly Batra was invited by the World Economic Forum to attend its Annual Summit at Davos in January 2016. This was a brilliant gathering of all who’s who from across the globe. No doubt this one invitation added greatly to our credibility and strength. But we believe that with recognition comes greater responsibility, and now our resolution is to accelerate our work with greater determination and courage, in order to expand our model to many more geographies. We shall move to more action, better results, higher impact.

Read Dr Shelly’s blog in Huffington post on her Davos experience:

And we are proud and humbled by our work. We have taken great strides in Cambodia, where we have trained more than 3000 people from remote villages as Community health Workers. These foot soldiers carry out TB detection and provide doorstep delivery of TB medicines to patients living in villages and far-flung areas, thus ensuring health and economic stability, and preventing the menace of Drug Resistance.

Drug resistance continues to be one of the biggest challenges. We prevent this by using eCompliance, the fingerprint technology to monitor every dose taken, and slowly but surely, eCompliance is becoming the gold standard for TB care. Our eCompliance has been replicated ASPAT, an NGO in Peru, by the name SisBiotic, to targets Peru’s TB high treatment abandonment rate. Aspat Peru received the Kochon award at the UNION conference in Cape Town last year, which is awarded annually by the Stop TB Partnership to individuals and/or organizations that have made a significant contribution to combating TB.

Work continues, and better than before. Each successive year makes us more determined. It is your unswavering and enduring support has helped us stay on this long and difficult path. If not for you, there would be no ‘going to scale’. If not for you, millions would still be dying of a curable disease. I thank you with all my heart.

Donation Utilization:

This quarter Operation ASHA raised $466.

Click here to read about Anita, mother of 3, battling tuberculosis.

Thank you.

Dec 15, 2015

Treating 3500 poor TB patients in India & Cambodia

Dear Friend,

As the year draws to its end, let’s take a moment to pause and reflect on what we have achieved, what are our goals, and what we must do to persevere on our chosen path.

Today I stand in spirit with the thousands who have no access to health, safe water, or sanitation. I stand hand in hand with the poorest of the poor, those who seek equality, justice, and a safe world. And I know you share my dream - that of health for all, for better health leads to better education and work and wages, and lifts people out of poverty.

Operation ASHA serves more than 8 million disadvantaged in India and Cambodia, and your support has been crucial to our success. Your donation help us treat 3,500 patients of a deadly disease, Tuberculosis. These patients come from urban shanties or far flung areas, and they have recovered and lived because of you.

Your donation are leveraged 4 times by the free medicines provided by the government. Your support matters. Because patients matter.

With your support Operation ASHA continues to achieve new milestones and set new standards.

Many exciting things have happened recently.

Dr. Shelly was also featured on AlJazeera's Inside Story on " Is the world losing the fight against 'superbugs; " Click here to see what she has to say. 

Operation ASHA is the first Indian NGO to be a part of WIPO Re:Search Consortium

Operation ASHA also won the 2015 FT/ IFC Transformational Business Award in the Information and Communications Technology category. We were the runners-up in 2014. 

Operation ASHA was featured in an episode of Accelerate India, on CNBC-TV18 in India, for its use of fingerprint-scanning to ensure adherence to medication and effective patient-provider communication.

Forbes magazine published an article by Will Greene featuring OpASHA for embracing new mobile health technologies to help fight TB efficiently and cost effectively. A leading newspaper in India, The Tribune, featured an article “TB control requires new technologies” talking about OpASHA’s novel model in the area of TB care. Click here to read this article.
Project Report

Donation Utilization:
This quarter Operation ASHA raised $174.

Click here to read about Anita, mother of 3, battling tuberculosis. 

We have been able to support these disadvantaged TB patients only because of your continued love and support. Make a donation today and help us go further in achieving our mission of eradicating tuberculosis.

Thank you.
WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.